SAN DIEGO--(BUSINESS WIRE)--Livara Health, a leader in value-based musculoskeletal (MSK) management, today announced that it has raised $15 million in Series B funding. The round was led by A1 Health Ventures, with participation from existing investors Polaris Partners, Providence Ventures, Martin Ventures, and a new strategic investor.
A centralized musculoskeletal care plan is essential for enhancing patient outcomes, reducing overall care costs, ensuring equitable access to care, and optimizing resource utilization and risk stratification. This new round of funding will accelerate the innovation of Livara’s technology and clinical capabilities to meet the need and potential of this transformative care delivery model.
Livara has treated over 120,000 people since its founding and entered 2024 with nearly 4 million people eligible to access its MSK management platform through both health plan and provider partnerships, including Medicare and commercially insured populations. Livara looks to grow all populations and manage additional risk for its partners, including assuming total cost of musculoskeletal care.
“At Livara, we are building a better musculoskeletal management solution, taking a biopsychosocial approach to patient care. Having treated patients for over 15 years through both virtual and in-person care pathways, we understand that delivering genuine patient-centered care requires a deep clinical program that can only be built through experience,” said Rob Cohen, Chief Executive Officer of Livara Health. “This new round of funding will help us expand our already proven healthier standard of care for musculoskeletal patients and broaden our proprietary care delivery model focused on ensuring appropriate care pathways for all patients.”
Through its fully integrated suite of solutions, Livara helps payors reduce unnecessary utilization, providers better manage complex MSK populations, and patients get the care they need when and where they need it.
“Livara is tackling one of healthcare’s most significant challenges with the potential to improve the experience, health and wellbeing of anyone who faces challenges in their orthopedic care,” said Jon Phillips, Managing Director of A1 Health Ventures. “We believe their virtual and in-person care delivery and care navigation solutions will have an enormous impact on the state of musculoskeletal care in the U.S. and we are thrilled to partner on actualizing this exciting vision.”
For more information, or to learn about partnering with Livara, please visit www.livarahealth.com
About Livara Health:
Livara Health (formerly SpineZone) is a value-based MSK management solution for innovative providers, payors, utilization management companies, and value-based health systems. By combining care planning, virtual first care delivery and care navigation, Livara has delivered exceptional patient outcomes for over 17 years. When compared to traditional conservative treatment options, Livara’s patients require fewer surgeries, injections and opioids. Livara partners with commercial and Medicare payors and providers through flexible value-based payment arrangements, including assuming total cost of MSK care. More information can be found at www.livarahealth.com
